Science Explorer Back to mapMap

Most cited papers in Antiplatelet Therapy and Cardiovascular Diseases

Antiplatelet Therapy and Cardiovascular Diseases

What are the most cited papers in Antiplatelet Therapy and Cardiovascular Diseases?

The most cited paper in Antiplatelet Therapy and Cardiovascular Diseases is "Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis" (Qinghua Zhang, Chao Wang, Maoyong Zheng et al., 2014), with 11,556 citations. Next come "European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)" (8,531) and "Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes" (7,154).

Showing 50 of 100 papers. Every paper with more than 1,265 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis Qinghua Zhang, Chao Wang, Maoyong Zheng et al. · Cerebrovascular Diseases ReviewOpen access 24 Dec 2014 11,556
2 European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) Authors/Task Force Members: et al. · European Heart Journal Open access 3 May 2012 8,531
3 Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Lars C. Wallentin, Richard C. Becker, Andrzej Budaj et al. · New England Journal of Medicine Open access 30 Aug 2009 7,154
4 Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et al. · New England Journal of Medicine Open access 4 Nov 2007 6,822
5 Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigato · New England Journal of Medicine Open access 16 Aug 2001 6,519
6 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Scott M. Grundy et al. · Circulation Open access 17 Jan 2019 6,261
7 Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lennart Hansson, Alberto Zanchetti, S. George Carruthers et al. · The Lancet Jun 1998 5,794
8 Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients Sam Schulman, Clive Kearon · Journal of Thrombosis and Haemostasis Open access Apr 2005 5,063
9 Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation Robert G. Hart, Lesly A. Pearce, Maria I. Aguilar · Annals of Internal Medicine 19 Jun 2007 4,830
10 A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation Ron Pisters, Deirdre A. Lane, Robby Nieuwlaat et al. · CHEST Journal Open access 18 Mar 2010 4,546
11 Standardized Bleeding Definitions for Cardiovascular Clinical Trials Roxana Mehran, Sunil V. Rao, Deepak L. Bhatt et al. · Circulation 14 Jun 2011 4,530
12 Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Ellen Catherine Keeley, Judith Boura, Cindy Lee Grines · The Lancet 2003 4,375
13 Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal G. V. R. Born · Nature Jun 1962 4,308
14 2012 focused update of the ESC Guidelines for the management of atrial fibrillation Authors Task Force Members et al. · EP Europace Open access 24 Aug 2012 3,829
15 Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients Sam Schulman, Ulf Angerås, David Bergqvist et al. · Journal of Thrombosis and Haemostasis Open access 30 Oct 2009 3,778
16 The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes Franklin H. Epstein, Valentı́n Fuster, Lina Badimon et al. · New England Journal of Medicine 30 Jan 1992 3,733
17 An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Salvador Moncada, Ryszard Jerzy Gryglewski, S Bunting et al. · Nature Oct 1976 3,608
18 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention Glenn N. Levine, Eric Bates, James C. Blankenship et al. · Circulation Open access 8 Nov 2011 3,304
19 The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI Elliott M. Antman, Marc C. Cohen, Peter J. L. M. Bernink et al. · JAMA 16 Aug 2000 3,276
20 Effects of Torcetrapib in Patients at High Risk for Coronary Events Philip J. Barter, Mark J. Caulfield, Mats A. L. Eriksson et al. · New England Journal of Medicine Open access 5 Nov 2007 3,168
21 Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents Ιoannis Iakovou · JAMA Open access 3 May 2005 3,137
22 Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention Steven R. Steinhubl, Peter B. Berger, James Tift Mann et al. · JAMA 20 Nov 2002 3,093
23 Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Mats Hámberg, Jan Olof Svensson, Bengt Samuelsson · Proceedings of the National Academy of Sciences Open access Aug 1975 3,065
24 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS Marco Valgimigli et al. · European Heart Journal Open access154 authors 26 Aug 2017 3,025
25 High-Dose Atorvastatin after Stroke or Transient Ischemic Attack The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Inv · New England Journal of Medicine Open access 9 Aug 2006 2,914
26 Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Lars Norgren, William R. Hiatt, John Dormandy et al. · European Journal of Vascular and Endovascular Surgery Open access 30 Nov 2006 2,868
27 Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events Deepak L. Bhatt et al. · New England Journal of Medicine Open access 12 Mar 2006 2,837
28 Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Shamir R. Mehta, Salim Yusuf, Ron J.G. Peters et al. · The Lancet Aug 2001 2,820
29 Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty The EPIC Investigators · New England Journal of Medicine Open access 7 Apr 1994 2,610
30 Cytochrome P-450 Polymorphisms and Response to Clopidogrel Jessica L. Mega, Sandra L. Close, Stephen D. Wiviott et al. · New England Journal of Medicine Open access 22 Dec 2008 2,503
31 Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease John W. Eikelboom et al. · New England Journal of Medicine Open access 27 Aug 2017 2,456
32 Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial Hans‐Christoph Diener, Julien Bogousslavsky, Lawrence M. Brass et al. · The Lancet Open access Jul 2004 2,303
33 ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article Sidney C. Smith et al. · Circulation 3 Jan 2006 2,226
34 Stroke Geoffrey Alan Donnan, Marc Fisher, Malcolm Robert Macleod et al. · The Lancet May 2008 2,224
35 Platelet Activation and Atherothrombosis Giovanni Davı̀, Carlo Patrono · New England Journal of Medicine 12 Dec 2007 2,157
36 Prevention of VTE in Nonorthopedic Surgical Patients Michael K. Gould, David García, Sherry M. Wren et al. · CHEST Journal Open access Feb 2012 2,137
37 Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation The ACTIVE Investigators · New England Journal of Medicine Open access 31 Mar 2009 2,107
38 A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy Frits R. Rosendaal, Suzanne C. Cannegieter, Felix J.M. van der Meer et al. · Thrombosis and Haemostasis Open access 1993 2,077
39 A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents Albert Schömig, Franz–Josef Neumann, Adnan Kastrati et al. · New England Journal of Medicine 25 Apr 1996 2,039
40 A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction Cindy Lee Grines, Kevin F. Browne, Jean Marco et al. · New England Journal of Medicine Open access 11 Mar 1993 2,004
41 Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction Marc P. Bonaca et al. · New England Journal of Medicine Open access 14 Mar 2015 2,003
42 A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women Paul M. Ridker, Nancy R. Cook, I‐Min Lee et al. · New England Journal of Medicine 7 Mar 2005 1,962
43 Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation Marc Steven Sabatine, Christopher Paul Cannon, Charles Michael Gibson et al. · New England Journal of Medicine 10 Mar 2005 1,935
44 Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents Laura Mauri et al. · New England Journal of Medicine Open access 16 Nov 2014 1,928
45 Mechanisms of Thrombus Formation Bruce Furie, Barbara C. Furie · New England Journal of Medicine 27 Aug 2008 1,925
46 Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization The EPILOG Investigators · New England Journal of Medicine Open access 12 Jun 1997 1,900
47 Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack Yongjun Wang, Yilong Wang, Xingquan Zhao et al. · New England Journal of Medicine Open access 26 Jun 2013 1,877
48 The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia Cindy E. Neunert, Wendy Lim, Mark Andrew Crowther et al. · Blood 16 Feb 2011 1,869
49 A Platelet-Dependent Serum Factor That Stimulates the Proliferation of Arterial Smooth Muscle Cells In Vitro Russell Ross, John Glomset, Beverly Kariya et al. · Proceedings of the National Academy of Sciences Open access Apr 1974 1,858
50 A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting Martin B. Leon, Donald S. Baim, Jeffrey J. Popma et al. · New England Journal of Medicine Open access 3 Dec 1998 1,826

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.